drugset / Trial / NCT02802592

EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)

NCT02802592

Phase 1/2 Terminated 4 enrolled Johns Hopkins University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)

Timeline

Start
2015-05
Primary completion
2016-06-15
Completion
2017-02-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator epoetin alfa Protein / enzyme biologic 1000 iu/kg